Shuttle Pharmaceuticals ... (SHPH)

0.55

-0.06 (-9.66%)

At close: Mar 03, 2025, 3:59 PM

0.56

2.67%

After-hours: Mar 03, 2025, 06:10 PM EST

Shuttle Pharmaceuticals Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY18	FY17
Net Income	-9.14B	-6.59M	-3.03M	-1.15M	-805.73K	-626.14K	-213.59K
Depreciation & Amortization	5.46M	6.81K	66.83K	60.83K	54.95K	18K	18.74K
Stock-Based Compensation	259.74M	181.96K	403.96K	910.07K	459.59K	n/a	n/a
Other Working Capital	n/a	66.57K	-172.32K	-3.65K	-106.02K	19.64K	10.83K
Other Non-Cash Items	1.55B	602.17K	402.41K	3.39K	256.58K	63.79K	58.51K
Deferred Income Tax	n/a	n/a	n/a	-641.65K	n/a	n/a	n/a
Change in Working Capital	n/a	220.63K	-555.21K	519.15K	7.78K	16.65K	-9.03K
Operating Cash Flow	-7.33B	-5.58M	-2.71M	-300.34K	-26.83K	-566.69K	-202.71K
Capital Expenditures	n/a	-19.05K	n/a	n/a	-10.82K	n/a	n/a
Acquisitions	n/a	3.02M	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	-3M	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	2.96B	187.9K	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-43.59M	-3.02M	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	2.92B	-2.83M	n/a	n/a	-10.82K	n/a	n/a
Debt Repayment	n/a	2.92M	600.72K	687.93K	70.07K	205.87K	160.52K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	-402.07K	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.76B	-345K	428.75K	n/a	n/a	-250K	n/a
Financial Cash Flow	3.76B	2.57M	10.62M	687.93K	70.07K	868.37K	160.62K
Net Cash Flow	-656.27M	-5.84M	7.91M	387.6K	32.42K	301.68K	-42.09K
Free Cash Flow	-7.33B	-5.6M	-2.71M	-300.34K	-37.65K	-566.69K	-202.71K